1 year ago



20 Deloitte Consulting.

20 Deloitte Consulting. In the face of uncertainty: A challenging future for biopharmaceutical innovation. dam/Deloitte/lu/Documents/life-sciences-health-care/us_consulting_Inthefaceofuncertainty_040614.pdf. Published 2014. Accessed March 2016. 21 Norris J, Schuber P, Tolman C. Trends in healthcare investments and exits 2016. Healthcare_Report/healthcare-report-2016.pdf. Published 2016. Accessed March 2016. 22 Deloitte. Forthcoming Report. 23 Alzheimer’s Disease Neuroimaging Initiative. Accessed March 2016. 24 PhRMA. Ebola: The biopharmaceutical industry remains committed to developing medical advances. default/files/pdf/ebola-backgrounder.pdf. Published October 2015. Accessed March 2016. 25 PhRMA. Zika virus: Current outbreak and ongoing research efforts. pdf. Published February 2016. Accessed March 2016. 26 Cleveland Clinic. Top 10 medical innovations for 2016. Top-10-for-2015-%281%29/Top-10-Articles/1-Mobile-Stroke-Treatment-Unit.aspx#.VpQTrfkrKM. Accessed March 2016. 44 Impact on the Economy and Biomedical Ecosystem

Research and Clinical Trials CHAPTER 4

you can read it here. - Ratbags
I've Got Nothing to Lose by Trying It - Sense About Science
Making a Killing AMENDED - Animal Aid
European Pharmaceutical Regulatory Law BOOT CAMP - Bristows
Eli Lilly and Company Corporate Citizenship ... -
Best Practice Model - Association of the British Pharmaceutical ...
I've Got Nothing to Lose by Trying It - Sense About Science